Sanofi Pays $109M For Fine Dining Kickbacks, Illicit Samples

Law360, New York (December 19, 2012, 5:54 PM ET) -- Sanofi-Aventis US Inc. will pay $109 million to settle a whistleblower's False Claims Act allegations that the company distributed improper free samples of arthritis drug Hyalgan and treated doctors to lavish meals in order to beat back competition from a lower-priced product, prosecutors said Wednesday.

The settlement stems from a qui tam complaint brought by former Sanofi sales representative Mark Giddarie, who will land an $18.5 million cut of the proceeds. According to the U.S. Department of Justice, Sanofi considered lowering its price in order to...
To view the full article, register now.

DEWEY LIVE BLOG

Follow our exclusive coverage of the trial of the year:

Catch up on the Dewey trial here